These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36356431)
21. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study. Giustozzi M; Vedovati MC; Verso M; Scrucca L; Conti S; Verdecchia P; Bogliari G; Pierpaoli L; Agnelli G; Becattini C Int J Cardiol; 2019 Apr; 281():56-61. PubMed ID: 30712846 [TBL] [Abstract][Full Text] [Related]
22. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013 [TBL] [Abstract][Full Text] [Related]
23. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry. Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H; J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259 [TBL] [Abstract][Full Text] [Related]
24. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K; Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346 [TBL] [Abstract][Full Text] [Related]
25. Ninety-Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke. Wilson G; Sharma M; Eagles D; Nemnom MJ; Sivilotti MLA; Émond M; Stiell IG; Stotts G; Lee J; Worster A; Morris J; Cheung KW; Jin AY; Oczkowski WJ; Sahlas DJ; Murray HE; Mackey A; Verreault S; Camden MC; Yip S; Teal P; Gladstone DJ; Boulos MI; Chagnon N; Shouldice E; Atzema C; Slaoui T; Teitlebaum J; Wells GA; Nath A; Perry JJ J Am Heart Assoc; 2023 Apr; 12(8):e026681. PubMed ID: 37026540 [TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study. Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A; CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273 [TBL] [Abstract][Full Text] [Related]
27. 5-year stroke rates in nonvalvular atrial fibrillation after watchman compared to direct oral anticoagulants. Khalid SI; Sathianathan S; Thomson KB; McGuire LS; Soni MC; Mehta AI J Cardiol; 2024 Mar; 83(3):163-168. PubMed ID: 37541428 [TBL] [Abstract][Full Text] [Related]
28. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
30. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines. Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry. Patti G; Pecen L; Casalnuovo G; Manu MC; Kirchhof P; De Caterina R Clin Res Cardiol; 2023 Nov; 112(11):1517-1528. PubMed ID: 35976428 [TBL] [Abstract][Full Text] [Related]
32. Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study. Kimura S; Toyoda K; Yoshimura S; Minematsu K; Yasaka M; Paciaroni M; Werring DJ; Yamagami H; Nagao T; Yoshimura S; Polymeris A; Zietz A; Engelter ST; Kallmünzer B; Cappellari M; Chiba T; Yoshimoto T; Shiozawa M; Kitazono T; Koga M; Stroke; 2022 May; 53(5):1540-1549. PubMed ID: 35105180 [TBL] [Abstract][Full Text] [Related]
33. Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis. Mosconi MG; Maraziti G; Paciaroni M; Giustozzi M; Vedovati MC; Bogliari G; Urbini C; Traballi L; Caso V Eur Neurol; 2023; 86(1):13-24. PubMed ID: 36099877 [TBL] [Abstract][Full Text] [Related]
34. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry. Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K; Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727 [TBL] [Abstract][Full Text] [Related]
35. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ? Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996 [TBL] [Abstract][Full Text] [Related]
36. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study. Admassie E; Chalmers L; Bereznicki LR J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis. Umashankar K; Mammi M; Badawoud E; Tang Y; Zhou M; Borges JC; Liew A; Migliore M; Mekary RA Cardiovasc Drugs Ther; 2023 Dec; 37(6):1225-1237. PubMed ID: 35467313 [TBL] [Abstract][Full Text] [Related]
38. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation. Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551 [TBL] [Abstract][Full Text] [Related]
39. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848 [TBL] [Abstract][Full Text] [Related]
40. Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry. Miyazaki S; Miyauchi K; Hayashi H; Yamashiro K; Tanaka R; Nishizaki Y; Nojiri S; Suwa S; Sumiyoshi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H J Cardiol; 2022 Jul; 80(1):41-48. PubMed ID: 35346556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]